Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4)
about
Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancerSkin problems and EGFR-tyrosine kinase inhibitorUnderstanding, recognizing, and managing toxicities of targeted anticancer therapies.Dermatologic toxicities in epidermal growth factor receptor and multikinase inhibitors.Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid TumorsDermatologic events from EGFR inhibitors: the issue of the missing patient voice.Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.Cetuximab in the treatment of patients with colorectal cancer.Cetuximab in non-melanoma skin cancer.Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management.Dermatological toxicity associated with targeted therapies in cancer: optimal management.Management of Dermatologic Complications of Lung Cancer Therapies.
P2860
Q26747335-3C8A2299-9F98-400C-9931-007E7F7251C2Q28069454-C06C7912-54BD-4D64-803D-319CED9B81EDQ33408049-BA35F9C8-4EAE-4B6D-9A1F-22B0004714CFQ33885559-F9626551-CBDE-4F05-A722-16892CC11DA7Q35083960-846C46C5-FBC4-4F1F-A954-7C4525F08A38Q36951089-C085C56D-BC7F-4ED4-A359-8846EAB781A6Q37496672-FF74DCDF-EE57-42C1-B58C-F701A010D287Q37541523-DCFF9BDD-5D96-44EF-A84C-DCFD20618865Q37644848-23E390FF-C42B-44C8-BADA-2083C8DCECB2Q37873948-F76AF1E2-2903-46CE-A928-5AEAF9894E80Q38004033-56EDC3C9-937E-4D78-80C0-CB42D8BAF1ECQ38133409-BF0ED983-2455-4110-949E-EF5851DF279FQ38239381-0F204266-C5FB-4C46-AE8F-C86037638091Q38580488-64AD3EF9-8DD4-4B82-820D-7982A3307C0A
P2860
Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4)
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@ast
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@en
type
label
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@ast
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@en
prefLabel
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@ast
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@en
P2093
P2860
P1433
P1476
Does sunscreen prevent epiderm ...... Cancer Treatment Group (N05C4)
@en
P2093
Abby Thrower
Aleksandar Sekulic
Aminah Jatoi
Bassam I Mattar
Charles L Loprinzi
Daniel A Nikcevich
Jeff A Sloan
Nicole Lea Wentworth-Hartung
Patrick J Flynn
Paul Novotny
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0082
P577
2010-08-26T00:00:00Z